InvestorRelations-1

Thomas Smeenk, the CEO of Hemostemix, on the new appointment new

Long
TSXV:HEM   HEMOSTEMIX INC

For settling all the financial transactions of the company, Hemostemix has appointed a special advisor, Mr. Richard Groome, to the CEO, who believes that he’s a great addition to the team.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.